Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial - Sivaprasad, S; Prevost, A T; Bainbridge, J (BMJ Open, 2015)